Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why CRISPR Therapeutics Stock Fell 18.4% in October

TheMotleyFool

0 0

Why CRISPR Therapeutics Stock Fell 18.4% in October

Shares of CRISPR Therapeutics (NASDAQ: CRSP) slid 18.4% in October, according to data from S&P Global Market Intelligence. The biotech stock lost ground after the company published weaker-than-expected trial results for one of its key clinical therapies.